EDELWEISS MSCI INDIA DOMESTIC & WORLD HEALTHCARE 45 INDEX vs Motilal Oswal BSE Healthcare ETF
Edelweiss vs Motilal· Portfolio Overlap Analysis
69.0%High Overlap
25 common stocksRank #3298 / 5,000
Investor takeaway: These funds overlap 69.0%. Holding both gives you almost no extra diversification. You are effectively paying two expense ratios for the same portfolio core.
Common Holdings (25)
| Stock | Wt% in EDELWEISS MSCI INDIA DOMESTIC | Wt% in Motilal Oswal BSE Healthcare E | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 11.25% | 13.46% | 11.25% |
Max Healthcare Institute Ltd. Healthcare Services | 5.73% | 5.92% | 5.73% |
Apollo Hospitals Enterprise Ltd. Healthcare Services | 5.69% | 5.86% | 5.69% |
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology | 5.17% | 5.99% | 5.17% |
Cipla Ltd. Pharmaceuticals & Biotechnology | 5.14% | 5.59% | 5.14% |
Dr. Reddy's Laboratories Ltd. Pharmaceuticals & Biotechnology | 4.71% | 5.75% | 4.71% |
Lupin Ltd. Pharmaceuticals & Biotechnology | 3.90% | 4.09% | 3.90% |
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 3.46% | 3.34% | 3.34% |
Fortis Healthcare Ltd. Healthcare Services | 3.12% | 3.60% | 3.12% |
Laurus Labs Ltd. Pharmaceuticals & Biotechnology | 2.55% | 3.06% | 2.55% |
Glenmark Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 2.24% | 2.35% | 2.24% |
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology | 2.15% | 2.50% | 2.15% |
Mankind Pharma Ltd. Pharmaceuticals & Biotechnology | 1.88% | 1.84% | 1.84% |
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology | 1.82% | 2.42% | 1.82% |
IPCA Laboratories Ltd. Pharmaceuticals & Biotechnology | 1.44% | 1.57% | 1.44% |
Biocon Ltd. Pharmaceuticals & Biotechnology | 1.41% | 2.04% | 1.41% |
Zydus Lifesciences Ltd. Pharmaceuticals & Biotechnology | 1.25% | 1.70% | 1.25% |
Aster DM Healthcare Ltd. Healthcare Services | 1.03% | 1.12% | 1.03% |
Gland Pharma Ltd. Pharmaceuticals & Biotechnology | 0.91% | 1.06% | 0.91% |
Narayana Hrudayalaya ltd. Healthcare Services | 0.88% | 0.91% | 0.88% |
Ajanta Pharma Ltd. Pharmaceuticals & Biotechnology | 0.88% | 0.93% | 0.88% |
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 0.73% | 0.77% | 0.73% |
Piramal Pharma Ltd. Pharmaceuticals & Biotechnology | 0.63% | 0.70% | 0.63% |
Global Health Ltd. Healthcare Services | 0.62% | 0.70% | 0.62% |
Syngene International Ltd. Healthcare Services | 0.52% | 0.59% | 0.52% |
Unique to EDELWEISS MSCI INDIA DOMESTIC
All top holdings are shared with the other fund.
Unique to Motilal Oswal BSE Healthcare E
All top holdings are shared with the other fund.
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology51.4% (18)
Healthcare Services17.6% (7)
More comparisons for EDELWEISS MSCI INDIA DOMESTIC
- vs Mirae Asset Nifty 500 Healthca67.9% · 25 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE64.1% · 19 stocks
- vs Axis NIFTY Healthcare ETF64.1% · 19 stocks
- vs DSP Nifty Healthcare ETF64.1% · 19 stocks
- vs ICICI Prudential Nifty Healthc64.1% · 19 stocks
More comparisons for Motilal Oswal BSE Healthcare E
- vs Mirae Asset Nifty 500 Healthca88.9% · 50 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE73.4% · 20 stocks
- vs Axis NIFTY Healthcare ETF73.4% · 20 stocks
- vs DSP Nifty Healthcare ETF73.4% · 20 stocks
- vs ICICI Prudential Nifty Healthc73.4% · 20 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.